Inventor · disambiguated record
Shuzhi Dong
Also filed as: DONG SHUZHI
22 granted patents·4 pending applications·50 citations·filing 2012–2022
93Inventor score
Top patents by PatentIndex Score
26 records- 0191US8952166B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2013·Granted Feb 10, 2015·17 cites·32 claims
- 0290US10221163B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·4 cites·67 claims
- 0386US9708336B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 18, 2017·4 cites·26 claims
- 0485US9839642B2Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 12, 2017·3 cites·19 claims
- 0583US10544130B2Metallo-beta-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jan 28, 2020·1 cites·20 claims
- 0678US9751881B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 0777US10227331B2Metallo-β-lactamase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Mar 12, 2019·1 cites·26 claims
- 0876US10000484B2Inhibitors of the renal outer medullary potassim channelMERCK SHARP & DOHME·Filed 2014·Granted Jun 19, 2018·1 cites·9 claims
- 0976US9839629B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·3 cites·16 claims
- 1075US9862720B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·2 cites·19 claims
- 1175US9850245B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Dec 26, 2017·2 cites·20 claims
- 1275US9765074B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Sep 19, 2017·1 cites·14 claims
- 1375US9206198B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Dec 8, 2015·2 cites·12 claims
- 1474US9718808B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Aug 1, 2017·2 cites·16 claims
- 1573US9604998B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2014·Granted Mar 28, 2017·2 cites·14 claims
- 1671US9062070B2Inhibitors of the renal outer medullary potassium channelPASTERNAK ALEXANDER·Filed 2012·Granted Jun 23, 2015·2 cites·15 claims
- 1764US9926317B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Mar 27, 2018·1 cites·11 claims
- 1861US11932637B2Chromane amidine monobactam compounds for the treatment of bacterial infectionsMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 19, 2024·0 cites·49 claims
- 1957US11207312B2Metallo-beta-lactamase inhibitors and methods of use thereofMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·14 claims
- 2044US2020375987A1Metallo-beta-lactamase inhibitors and methods of use thereofPASTERNAK ALEXANDER·Filed 2018·Application pending·0 cites
- 2141US2017275292A1Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2241US2017275298A1Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2340US2017275302A1Inhibitors of the renal outer medullary potassium channelPASTERNAK ALEXANDER·Filed 2015·Application pending·0 cites
- 2437US10160751B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·0 cites·14 claims
- 2534US10208064B2Inhibitors of the renal outer medullary potassium channelMERCK SHARP & DOHME·Filed 2015·Granted Feb 19, 2019·0 cites·9 claims
- 2622US11180504B2Substituted carbapenems for the treatment of bacterial infectionsORCHID PHARMA LTD·Filed 2017·Granted Nov 23, 2021·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Shuzhi Dong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →